AnazaoHealth Corporation – FDA 483, Jul 29, 2022
AnazaoHealth Corporation, an outsourcing facility in Las Vegas, NV, was cited for significant quality control and manufacturing deficiencies during an FDA inspection. Observations included a lack of quality unit authority over production records and investigations, absence of written production procedures, inadequate batch failure investigations linked to serious adverse events, and unvalidated sterility test methods. Additionally, aseptic processing areas were found to have deficient cleaning and disinfection systems due to improper equipment storage.
ID · 9e352c51-977a-4b01-ac76-d78802a1413a
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.